Products for Research Use Only
RegisterLogin

AZ-1355

CAT: 0804-HY-101692-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-101692-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
AZ-1355 is an orally active and effctive lipid-lowering agent. AZ-1355 inhibits platelet aggregation in vivo and elevates the prostaglandin I2/thromboxane A2 ratio in vitro[1].
CAS Number
75451-07-9
UNSPSC
12352005
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Endocrinology; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/AZ-1355.html
Purity
98.19
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC=C2OC3=C(OC)C=CC=C3CNC2=C1)OCC
Molecular Formula
C17H17NO4
Molecular Weight
299.32
References & Citations
[1]Wada S, et al. The lipid-lowering profile in rodents. AZ-1355, a new dibenzoxazepine derivative. Atherosclerosis. 1981 Nov-Dec;40 (3-4) :263-71.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IP; TXA2/TP

Related Products

CatalogName
HY-100873-01PF-1355
HY-162702-01AZ'3137
HY-18112AZ-4217
HY-162353-01AZ'9567
HY-100873RPF-1355 (Standard)
HY-P1094AZ-10417808
HY-110122-01AZ 12216052
HY-15590-01AZ-23
HY-108670-01AZ 11645373
HY-153320AZ-TAK1

Alternative Products

CatalogName
BA5741-1AZ-1355
A19836-25AZ-1355 25mg
A19836-200AZ-1355 200mg
A19836-100AZ-1355 100mg
A19836-5AZ-1355 5mg
A19836-1AZ-1355 1mg
A19836-50AZ-1355 50mg
A19836-10AZ-1355 10mg
A19836-10mM-DAZ-1355 10mM * 1mL in DMSO
BA3444-10PF-1355

Popular Products